Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

de Sanjose, S., Quint, W. G., Alemany, L., Geraets, D. T., Klaustermeier, J. E., Lloveras, B., Tous, S., Felix, A., Bravo, L. E., Shin, H.-R., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70230-8 · Cited by 2,728

Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis

de Martel, C., Georges, D., Bray, F., Ferlay, J., & Clifford, G. M. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30488-7 · Cited by 2,475

Against which human papillomavirus types shall we vaccinate and screen? the international perspective

Muñóz, N., Bosch, F. X., Castellsagué, X., Díaz, M., de Sanjosé, S., Hammouda, D., Shah, K. V., & Meijer, C. J. L. M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20244 · Cited by 1,095

Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication

Li, N., Franceschi, S., Howell‐Jones, R., Snijders, P. J. F., & Clifford, G. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25396 · Cited by 1,067

PROPORTION OF DISEASE CAUSED OR PREVENTED BY A GIVEN EXPOSURE, TRAIT OR INTERVENTION1

MIETTINEN, O. S. (1974) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a121617 · Cited by 1,036

Human papillomavirus types in 115,789 HPV‐positive women: A meta‐analysis from cervical infection to cancer

Guan, P., Howell‐Jones, R., Li, N., Bruni, L., de Sanjosé, S., Franceschi, S., & Clifford, G. M. (2012) · International Journal of Cancer · doi:10.1002/ijc.27485 · Cited by 927

Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline

SCHIFFMAN, M. H., Clifford, G. M., & Buonaguro, L. (2009) · Infectious Agents and Cancer · doi:10.1186/1750-9378-4-8 · Cited by 463

One virus, one lesion—individual components of CIN lesions contain a specific HPV type

Quint, W. G. V., Jenkins, D., Molijn, A. C., Struijk, L., van de Sandt, M. M., Doorbar, J., Mols, J., HOOF, C. V., Hardt, K., Struyf, F., et al. (2011) · The Journal of Pathology · doi:10.1002/path.3970 · Cited by 196

Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer

Clifford, G. M., Tully, S., & Franceschi, S. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix135 · Cited by 196

Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants

Wentzensen, N., SCHIFFMAN, M. H., Dunn, T., Zuna, R. E., Gold, M. A., Allen, R. A., Zhang, R., Sherman, M. E., Wacholder, S., Walker, J. L., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24528 · Cited by 186

PPP1R13L drives cervical cancer progression by suppressing p63-mediated PTEN transcription

Wang, A., Liu, X., Liang, Z., Yao, S., Wan, S., Ren, H., Gao, Y., Wang, H., & Cai, H. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05598-9 · Cited by 2

HPV genotyping agreement between paired cervical cytological sample and biopsy across lesion severity and vaccination

Chen, S., Du, Q., Yin, J., Xu, X., Chen, W., Pan, Q., Zhang, X., Hong, Y., Zhang, W., Liu, B., et al. (2025) · Virology Journal · doi:10.1186/s12985-025-02791-x · Cited by 2

Validation of Human Papillomavirus Genotyping by Oxford Nanopore Sequencing in Formalin-Fixed, Paraffin-Embedded Tissues and ThinPrep Anal and Gynecologic Samples

Hernández, C., Patiño, L. H., Camargo, M., Wang, C. Y., Chen, F., Liggayu, B., Cao, L., Cordon‐Cardo, C., Sordillo, E. M., Paniz‐Mondolfi, A., et al. (2025) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2025.04.010 · Cited by 2

Predictive role of ARID1A and B2M mutations and the antigen presentation pathway in the efficacy of definitive chemoradiotherapy for cervical cancer

Zhu, C., Gong, Z. H., Yin, P., Huang, J., He, D., Zhu, B., Wu, Y., Wang, H., Zhang, Y., Jing, Q., et al. (2025) · The Oncologist · doi:10.1093/oncolo/oyaf133 · Cited by 2

Comparative clinical performance of Alinity m HR HPV, cobas 4800 HPV, and cobas 6800 HPV for cervical cancer screening

Huang, S., Gentil, L. G., Schmidt, C., Cullum, R. L., Zhang, Y., Nelson, K., Lucic, D. X., & Abravaya, K. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.00589-25 · Cited by 2

Role of NTRK Fusion Genes in the Tumor Immune Microenvironment of HPV (+/−) Cervical Cancer

Wang, Q., Zhang, C., Liu, S., Li, W., Wei, W., Aziz, A. U. R., Han, L., & Wang, D. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70564 · Cited by 2

Cost-effectiveness and epidemiological impact of gender-neutral vaccination against human papillomavirus in economically developed metropolises of Beijing, Shanghai, and Guangzhou, China

Fu, X., Zhang, Q., Wagner, A. L., Zhou, W., Xia, Y., & Lu, Y. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2557092 · Cited by 2

Evaluation of targeted next‐generation sequencing for detection of HPV genotypes and sublineages in cervical liquid‐based cytology SurePath samples from the Danish screening program

Andersen, K. Y., Bonde, J. H., Waldstrøm, M., Jakobsen, M. V., Lamy, P., Pedersen, H., Bønløkke, S., Stougaard, M., & Steiniche, T. (2025) · International Journal of Cancer · doi:10.1002/ijc.70148 · Cited by 2

Single-cell analysis identifies PI3+S100A7+keratinocytes in early cervical squamous cell carcinoma with HPV infection

Fan, P., Dong, D., Feng, Y., Zhu, X., & Wang, R. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003795 · Cited by 2

High risk human papillomavirus versus cytological screening over two rounds in Finnish screening programme for cervical cancer: population based cohort study

Turunen, I. J., Kalliala, I. E. J., Pankakoski, M., & Partanen, V. (2025) · BMJ Medicine · doi:10.1136/bmjmed-2025-001435 · Cited by 2

Participation in cervical cancer screening among migrants and non-migrants in primary healthcare in Lisbon: a register-based study

Madeira, C. G., Marotta, C., Ditter, A. G., & Raviglione, M. C. (2025) · BMJ Global Health · doi:10.1136/bmjgh-2025-019061 · Cited by 2

Maximizing impact: the power of early HPV vaccination for long-term protection―lessons from a systematic review and meta-regression analysis

Navarro-Torné, A., Aris, E., Callegaro, A., Benninghoff, B., Yun, H., & Vetter, V. (2026) · Journal of Public Health · doi:10.1093/pubmed/fdag002 · Cited by 2

Clinical relevance of partial HPV genotyping in cervical cancer screening

Leino, A., Numminen, E., Kares, S., Meriö, M., Kotaniemi‐Talonen, L., Kholová, I., & Louvanto, K. (2026) · Scientific Reports · doi:10.1038/s41598-026-36594-z · Cited by 2

Clinical epidemiology and associations between HPV infection and vaginal infections in Jinan, China: a cross-sectional analysis

Chen, X., Zhou, H., Li, R., Li, R., & Liu, P. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1775865 · Cited by 2

The role of long non-coding RNAs in therapy resistance of cervical cancer and therapeutic potential

He, Z., Hao, H., Li, X., Ji, Y., Zhao, K., Zhang, L., Jin, Y. C., & Wang, X. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1746979 · Cited by 2

HPV vaccine scale-up is key to curb rising cervical cancer inequalities

Clifford, G. M. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00498-8 · Cited by 2

Prevalence and genotype distribution of cervical human papillomaviruses infection across cytology: A nationwide, cross-sectional study of over 1 million Chinese women from 2020 to 2024

Gao, D., Wang, X., Juan, J., Bi, H., Li, J., Shi, Y., Xu, T., Wang, Y., Zhao, G., & Zhang, X. (2026) · Journal of Infection · doi:10.1016/j.jinf.2026.106773 · Cited by 2

Toll-like receptors: versatile players in tumor

Yang, Y., & Pi, R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1735188 · Cited by 2

Prevalence and genotype distribution of human papillomavirus in cervical cancer and precancer in Japan between 2012 and 2025: a retrospective single-center study

Nakamura, H., Mori, S., Ishii, Y., Takeuchi, T., Tanaka, K., Imai, A., Matsui, T., Iwata, T., Yamagami, W., & Kukimoto, I. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1857364 · Cited by 2

Microbiome–Metabolome Crosstalk in HPV Pathogenesis: From Ecosystem Dynamics to Translational Biomarkers

Molina, M. A., & Dai, W. (2026) · Computational and Structural Biotechnology Journal · doi:10.34133/csbj.0158 · Cited by 2

Photodynamic therapy: a promising alternative for high-grade squamous intraepithelial lesion treatment

Termini, L., Castanheira, C. P., Lorenzi, N. P. C., Boccardo, E., Lisboa-Nascimento, T., Baptista, M. S., Inada, N. M., & Martins, W. K. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1899399 · Cited by 2

How to evaluate and select cervical screening and triage tests in vaccinated populations

Wentzensen, N., Arbyn, M., & Poljak, M. (2026) · JNCI Monographs · doi:10.1093/jncimonographs/lgag013 · Cited by 2

Inferred functional microbiome features are associated with clinical trajectories of low-grade cervical lesions

Stosic, M. S., Molina, M. A., Mukhedkar, D., Hassan, S. S., Sahlin, A., Ballester, C. R., Wang, J., & Mühr, L. S. A. (2026) · BMC Microbiology · doi:10.1186/s12866-026-05648-7 · Cited by 2

The Lineage and Sublineage Investigation of Human Papillomavirus Type 16 in Tehran, Iran, During 2022–2023: A Cross‐Sectional Study

Khezeli, Z., Shoja, Z., Kaffashian, M., Soleimani‐Jelodar, R., & Jalilvand, S. (2025) · Health Science Reports · doi:10.1002/hsr2.70680 · Cited by 2

DNA hypomethylation modification promotes BST2 expression in cervical cancer by facilitating STAT1 binding to the promoter of BST2

Wubuli, R., Ainiwaer, Z., Niyazi, M., & Han, L. (2025) · Infectious Agents and Cancer · doi:10.1186/s13027-025-00670-2 · Cited by 3

HPV burden in Armenia among unvaccinated women: a series of cross-sectional population-based prevalence surveys

Baussano, I., Tenet, V., Baghdasarova, K., Harutyunyan, Z., Vorsters, A., Heideman, D. A. M., Bleeker, M. C. G., Rüttimann, R. W., & Sahakyan, G. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127405 · Cited by 2

Validation of TypeSeq2, a Next-Generation–Based Sequencing Assay for the Detection of 46 Human Papillomavirus Genotypes, at the US National Cancer Institute and Costa Rica Laboratories

Sierra, M. S., Coto, C., Porras, C., Herrero, R., Ugalde, D., Sauer, A. N., Mora, D., Montes, C. P., Schussler, J. E., Hoffman, A. C., et al. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf369 · Cited by 2

Advancements and Future Perspectives of Human Papillomavirus (HPV) Vaccination in Latin America: Insights from Recent Decades

dos Santos, M. B., Arenhardt, M. P., Giannecchini, G. V., Gomes, L. M., da Silva, J. L., de Andrade, D. A. P., & de Melo, A. C. (2025) · Healthcare · doi:10.3390/healthcare13192502 · Cited by 2

Protocol for a cervical screening implementation trial comparing two approaches for delivering HPV self-collection in low-resource settings in India: a type 3 hybrid cluster randomised controlled trial (SHE-CAN)

Oommen, A. M., Ashfaq, M., Tonsing, M. V., Cherian, A. G., Singarayar, P., Viswanathan, V., Muniswamy, V., Hawkes, D., Abraham, P., Pricilla, R. A., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-101599 · Cited by 1

Evaluation of cervical cancer screening strategies in women living with HIV in Thailand

Sripan, P., Prouté, M., Ngo‐Giang‐Huong, N., Rangdaeng, S., Putiyanun, C., Halue, G., Leenasirimakul, P., Thongpaen, S., Buranabanjasatean, S., Cœur, S. L., et al. (2025) · 癌症：英文版 · doi:10.1002/cac2.70000 · Cited by 1

Improved cervical screening using HPV type restriction and cycle threshold limit setting with the AmpFire assay: A prospective screening cohort of women with and without HIV in Botswana

Luckett, R. L., Ramogola‐Masire, D., Moyo, S. M., Gompers, A. D., Modest, A. M., Moraka, N. O., Kashamba, T., Tawe, L., Noubary, F., Kuhn, L., et al. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70074 · Cited by 1

Innovative Noninvasive HPV Screening Using a Feminine Pad: A Pilot Study for Enhanced Cervical Cancer Detection

Aldariz-Amaya, R., Rodríguez-Esquivel, M., Ruiz-Romero, J. A., Anthor, F., Mares, E., Flores-Martínez, A., Gómez-Villa, E. A., Fuentes-García, M. A., Apresa-García, T., López-Romero, R., et al. (2025) · Obstetrics and Gynecology International · doi:10.1155/ogi/9344596 · Cited by 1

HPV-16 lineages among women in Africa: a systematic review with meta-analysis

Akinyi, I., Ferreira, M. T., Lopez, R. V. M., Onyango, F., Osundwa, D., Awandu, S. S., & Bogers, J. (2025) · Systematic Reviews · doi:10.1186/s13643-025-02891-3 · Cited by 1

Higher plasma AFB1 concentration is associated with increased risk of HPV 16 and HPV 18 detection and persistence among Ugandan women

Tong, Y., Nakalembe, M., Mpamani, C., Nakisige, C., Namugga, J., Banturaki, G., Tonui, P., Orang’o, O., Muthoka, K., Ngeresa, A., et al. (2025) · Environmental Health · doi:10.1186/s12940-025-01197-0 · Cited by 1

Assessing the influence of male vaccination on cervical cancer elimination in China under different vaccination coverage scenarios: A modeling study

Diakite, I., Kyle, J., Situ, S., Wang, W., Zhang, X., Wang, Y., Bian, R., Wu, H., Wang, X. S., Chen, Y., et al. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2528426 · Cited by 1

The Allplex HPV HR Detection assay fulfils international guideline requirements for primary cervical screening on SurePath samples and qualifies as a second-generation HPV comparator test

Oštrbenk, A., Pedersen, H., Poljak, M., & Bonde, J. H. (2025) · Journal of Clinical Virology · doi:10.1016/j.jcv.2025.105853 · Cited by 1

Human papillomavirus (HPV) vaccine effectiveness against anal HPV-16 and HPV-18 infections among young men who have sex with men visiting the sexual health center of Amsterdam (HPV4M): study protocol of an observational study

van Veelen, S., Alberts, C. J., Hoornenborg, E., Bruisten, S. M., Vermeij, K., van der Klis, F. R. M., Noordpool, L., Bogaards, J. A., & van der Loeff, M. F. S. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-101634 · Cited by 1

Cervical cytology-based screening identifies trichomonas vaginalis as a significant correlate of non-16/18 high-risk human papillomavirus infection in high-altitude tibetan agro-pastoral communities: A cross-sectional study of 62,657 women

Chen, M., Lhamo, Y., Chödrön, K., & Chen, L. (2025) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2025.108034 · Cited by 2

Identification of Bacterial Lipopolysaccharide-Related Molecular Subtypes and Development of a Four-Gene Prognostic Risk Model in Cervical Cancer

Tong, Y., Xu, L., Sun, Y., Zhang, K., & Fu, X. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s537092 · Cited by 1

Phylogenetics and selective pressure analysis of human papillomavirus types 31 and 33 variants in Eastern China

Wang, Y., Qu, W., Zhou, Q., Gong, Y., Wang, Y., Chen, F., Mo, J., Lin, L., Bi, T., Shi, W., et al. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11489-y · Cited by 1

HPV testing in cervical cancer formalin-fixed paraffin embedded tissues: Reliability of the Xpert HPV test and high-risk HPV genotypes distribution in Tunisia

Taher, Y. A., Rekaya, M. B., Romdhane, E., Miladi, B., Kacem, L. B. H., H’mayada, A. M., Mansour, N. B., Sassi, F., Chelbi, E., Tangour, M., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0333600 · Cited by 1

Revisiting HPV vaccination post-COVID: geopolitical, sociocultural, and ethical disparities in global health

Sad, S. A., Iftikhar, L., & Chamout, M. (2025) · International Journal for Equity in Health · doi:10.1186/s12939-025-02669-y · Cited by 1

Designing a Multi-Epitope Vaccine Against HPV 16, 18, 33, and 45 Targeting L1 and E7 Proteins: An Immunoinformatics Approach for Cervical Cancer Prevention and Therapy

Tusar, M. T. T., Haq, N., Gazi, H. R., Farazi, R., Bhuya, M. S. I., Haque, M. E., Hossain, M. G., & Abdullah-Al-Jubayer (2025) · Bioinformatics and Biology Insights · doi:10.1177/11779322251391076 · Cited by 1

Nicotine Activates PI3K/AKT Pathway to Induce Cellular Proliferation, Invasion, and Migration in HPV‐16 Positive Cervical Cancer SiHa Cells

Wang, J., Hu, Y., Gong, J., Chen, L., Zhang, L., & Wang, H. (2025) · Journal of Applied Toxicology · doi:10.1002/jat.70019 · Cited by 1

The public health impact of extending the catch-up nonavalent human papillomavirus vaccination program to 2028 in Japan: a model-based study

Diakite, I., Tobe, K., You, X., Chen, Y., Palmer, C., & Matsuki, T. (2025) · BMC Public Health · doi:10.1186/s12889-025-25684-8 · Cited by 1

Facile solid-liquid biphasic PCR platform for ultrasensitive multiplex detection and genotyping of HPV

Lu, Z., Zeng, W., Liu, S., Cao, R., Nilghaz, A., & Zhang, L. (2025) · Microchimica Acta · doi:10.1007/s00604-025-07678-w · Cited by 1

Social Determinants of Human Papillomavirus Vaccine Uptake Among Adolescent Girls in Low-Middle-Income Countries: A Systematic Review & Meta-Analysis

Kumar, P., Ray, A., Hora, R., Kumari, A., Singh, K., Mehra, R., Kaur, A., Singh, S. K., Koshal, S. S., Singh, V. K., et al. (2025) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/00469580251399368 · Cited by 1

Human Papillomavirus Genotype Landscape Across Cervical Cytology Grades and Impact of HIV Among Women of Eastern Cape Province, South Africa

Kondlo, S., Giyose, N., Businge, C. B., & Mbulawa, Z. Z. A. (2025) · Viruses · doi:10.3390/v18010065 · Cited by 1

Expectant management or conization for persistent low-grade cervical intraepithelial neoplasia: Analysis of 5-year outcomes

Bogani, G., Sopracordevole, F., Corso, G., Vizza, E., Scollo, P., Giannini, A., Donato, V. D., Ciavattini, A., Vincenzo, R. D., Gardella, B., et al. (2026) · Tumori Journal · doi:10.1177/03008916251395597 · Cited by 1

Circulating genotypes of human papillomavirus in adult women of reproductive age from the Boeny region of Madagascar: a cross-sectional study to explore needs and opportunities for HPV vaccination in the country

Garsevanidze, E., Kislaya, I., Kutz, J.-M., Rasamoelina, T., Ratefiarisoa, S., Razafindrakoto, R., Rasolojaona, Z. T., Razafindralava, N. M., Totofotsy, O., Zafinimampera, A. O., et al. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-12691-2 · Cited by 1

The R2TP complex stabilises E7 to drive human papillomavirus-mediated pathogenesis in cellular models of cervical cancer

Shadang, M., Arumugam, A., Singh, D. K., Keshari, P., Mathur, S., Iyer, V. K., Singhal, S., Chauhan, S. S., Akhter, Q., & Mir, R. A. (2026) · Virology Journal · doi:10.1186/s12985-026-03070-z · Cited by 1

Effectiveness analysis and clinical application potential exploration of combined detection of PAX1/JAM3 gene methylation in early diagnosis of cervical precancerous lesions

Fan, G., Xiaolu, Y., Keremu, Y., Kong, W., Xiaohui, X., & Xiumin, M. (2026) · Clinical Epigenetics · doi:10.1186/s13148-026-02095-z · Cited by 1

The Long-Term Effect of 2 and 3 Doses of Bivalent HPV Vaccination Against HPV Infections: A Comparison Between 2 Observational Cohort Studies

Middeldorp, M., Duijster, J. W., Hoeve-Bakker, B. J. A., Berkhof, J. H., & de Melker, H. E. (2026) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiag167 · Cited by 1

Twelve-year trends in cervical cytology screening: a retrospective analysis of 83,148 smears from a Turkish tertiary care center

Güzelbağ, B., Uzuner, E. G., SELÇUK, M., Ermin, S., Selcuk, C. G. O., & Çim, N. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1818289 · Cited by 1

Female genital schistosomiasis, including zoonotic and hybrid schistosomes, and other cervicovaginal co-infections

Lamberti, O., Kumwenda, D., Kelly, H., Kamfwa, P., Kayuni, S. A., Stothard, J. R., & Bustinduy, A. L. (2026) · The Lancet Microbe · doi:10.1016/j.lanmic.2026.101425 · Cited by 1

Burden of HPV-associated cancers in Peruvian men: Evidence from national health data

Otoya, I., Blas, M. M., da Silva, Z. M., Pereira, C. V., Orengo, J. C., Pungartnik, P. C., & Parellada, C. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2684106 · Cited by 1

Human Papilloma Virus (HPV) prevalence and genotype distribution among women in Karachi, Pakistan

Jilani, S. M., Iftner, A., Iqbal, H., tul-Wahab, A., Choudhary, M. I., Fayyaz, S., Rehm, T. M., & Iftner, T. (2026) · Journal of Virus Eradication · doi:10.1016/j.jve.2026.100631 · Cited by 1

Epidemiological characteristics and genotype distribution of low-risk human papillomavirus infection among women in Jingzhou, Central China: a cross-sectional study

Zheng, S., Wu, X., Li, W., Xu, X. J., & Gong, P. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13885-4 · Cited by 1

Natural killer cells against viral infection: from basic biology to immunotherapy

Zhang, Z., Wang, F., Liu, R., Tian, L., Cai, L., & Deng, Y. (2026) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbag020 · Cited by 1

Co-managing the double burden: strategies for simultaneously tackling infectious and non-communicable diseases

Li, J., Mei-lan, F., Kong, L.-F., Zhao, Z.-Y., Ohore, O. E., Bergquist, R., Tanner, M., & Yang, G. (2026) · Infectious Diseases of Poverty · doi:10.1186/s40249-026-01477-y · Cited by 1

The oncogenic role of mir-21 in cervical cancer: linking epithelial–mesenchymal transition to stromal remodeling

Galvis, I., Hafeez, A., Philip, J., & Salvatore, M. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1814515 · Cited by 1

Analysis of the clinical utility of p16/Ki-67 dual staining in screening cervical lesions among women positive for high-risk HPV

Zhang, Q., Lin, Y., Bao, L., & Huang, Q. (2026) · Medicine · doi:10.1097/md.0000000000050102 · Cited by 1

Deintensification of cervical cancer screening in the era of high human papillomavirus–vaccination coverage

Bonde, J. H., & Castle, P. E. (2026) · JNCI Monographs · doi:10.1093/jncimonographs/lgag010 · Cited by 1

Developments in human papillomavirus vaccines, schedules, and implementation strategies

Bruni, L., Brotons, M., Alvarez, J., & Roden, R. B. S. (2026) · JNCI Monographs · doi:10.1093/jncimonographs/lgag015 · Cited by 1

Optimising Human Papillomavirus Vaccination Strategies for Faster Cervical Cancer Elimination

Dillner, J. (2026) · Acta Paediatrica · doi:10.1111/apa.70756 · Cited by 1

Study on the Clinical Characteristics, Persistent Infection Ability and Viral Load of Human Papillomavirus Type 73 Single Infection

Chen, Z., Nie, S., Ran, J., Wang, Y., Li, Q., Zhao, H., Chen, X., Xiong, D., & Xiao, D. (2024) · Journal of Medical Virology · doi:10.1002/jmv.70097 · Cited by 1

Molecular detection of hrHPV-induced high-grade squamous intraepithelial lesions of the cervix through a targeted RNA next generation sequencing assay

Thiesen, J. F., Jacquemet, E., Campagne, P., Chatelain, D., Brochot, É., Herpe, Y.-É., Dheilly, N. M., Bouilloux, F., Rognon, B., Douablin, A., et al. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01238-x · Cited by 1

Algorithm for Organizing and Implementing Immunization Against Cervical Cancer: A Literature Review

Tankeyeva, D. A., Tashimova, Z. K., Urazayeva, A. B., Kumar, G. B., & Nurmukhamedova, S. M. (2025) · Journal of Environmental Treatment Techniques · doi:10.18502/jett.v13i2.18798 · Cited by 1

Short-term HPV detection dynamics across hormonal contraceptive methods in adolescent girls and young women: a secondary analysis of a randomized trial in South AfricaPreprint

Tanko, R. F., Taku, O., Mbulawa, Z. Z. A., Phohlo, K., Konstantinus, I. N., Balle, C., Pidwell, T., Happel, A., Gill, K., Bekker, L., et al. (2025) · medRxiv · doi:10.1101/2025.01.14.25320519 · Cited by 1

The effect of bivalent HPV vaccination against invasive cervical cancer and CIN3+ in the Netherlands: a national linkage studyPreprint

Middeldorp, M., Brouwer, J. G. M., Duijster, J. W., Knol, M. J., van Kemenade, F. J., Siebers, A. G., Berkhof, J. H., & de Melker, H. E. (2025) · medRxiv · doi:10.1101/2025.02.27.25322519 · Cited by 1

Prevalence and Genotype Distribution of Human Papilloma Virus (HPV) among Women in Karachi, PakistanPreprint

Jilani, S. M., Iftner, A., Iqbal, H., Atia-tul-Wahab, Fayyaz, S., Iftner, T., & Choudhary, M. I. (2025) · medRxiv · doi:10.1101/2025.06.20.25329989 · Cited by 1

Diagnostic Accuracy and Acceptability of a Novel Human Papillomavirus Self-Collection Tool for Cancer Screening in Eco-nomically Developed Regions: A Prospective Cohort Study in Shanghai, ChinaPreprint

Xu, B., Liu, J., Li, H., Zhang, T., & Li, F. (2025) · Research Square · doi:10.21203/rs.3.rs-7693739/v1 · Cited by 1

Comprehensive management of cervical cancer

Bañuelos, J., Ozores, P. P., Baltar, M. E. A., López, C. R., Corbacho, D. P., García, M. T. C., Mosquera, A. C., Paniagua, M. D. L. L. C., Lagares, A., & Pazos, A. M. V. (2024) · Revisiones en cáncer · doi:10.20960/revcancer.00091

Cervical cancer epidemiology

de Sanjosé, S., & Pérez, R. I. (2024) · Revisiones en cáncer · doi:10.20960/revcancer.00092

The second generation of domestic HPV vaccine based on Escherichia coli expression system can induce high titer neutralizing antibodies

Zhu, K., Bi, Z., Chen, Q., Zhong, G., Wu, T., Zhang, J., & Xia, N. (2024) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2024-0880

Viral integration and fusion transcript characteristics of possibly high-risk HPV in cervical cancer

Liu, H., Xu, R., Chen, J., Wang, S., Wang, L., Wu, M., & Wang, H. (2025) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2025.105746

EPIDEMIOLOŠKE KARAKTERISTIKE HEMORAGIJSKE GROZNICE SA BUBREŽNIM SINDROMOM U CRNOJ GORI OD 2014-2023.

Rakočević, B., Medenica, S., Adžić, B., & Zeković, Ž. (2025) · Praxis medica · doi:10.70949/pramed202503000r

Detection Rate, Genetic Polymorphism, Viral Load, Persistent Infection Capacity, and Pathogenicity of Human Papillomavirus Type 58

Chen, Z., Cheng, Q., Mu, X., Liu, Y., Zhang, M., Tian, D., Huang, Y., Bai, X., Yang, Y. F., & Li, Q. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70502

Constructing a causal attribution scale for physical education teachers for physical education lessons in maysan governorate

Al-Krizi, M. M. H. (2025) · JURNAL PENDIDIKAN OLAHRAGA · doi:10.37630/jpo.v15i4.3338

Social Determinants of Human Papillomavirus Vaccine Uptake Among Adolescent Girls in Low-Middle-Income Countries: A Systematic Review & Meta-AnalysisPreprint

Kumar, P., Ray, A., Hora, R., Kumari, A., Singh, K., Mehra, R., Kaur, A., Singh, S. K., Koshal, S. S., Singh, V. K., et al. (2025) · medRxiv · doi:10.1101/2025.08.21.25334143

Human papillomavirus, sexually transmitted infections, and antimicrobial resistance in West Africa: Estimating population burden and understanding exposures to accelerate vaccine impact and drive new interventions: The PHASE survey protocol

Bashorun, A. O., Kotei, L., Jallow, A. F., Jawla, O., Richard-Ugwuadu, E. U., Jagana, M., Bah, L., Bah, A. T., Conteh, K., Jallow, M. S. K., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0332842

Cervical HPV 18 detection is associated with high-grade cervical dysplasia in Kenyan and Ugandan women living with HIV

Nakalembe, M., Mpamani, C., Namugga, J., Nakisige, C., Banturaki, G., Tonui, P. K., Itsura, P. M., Orang’o, O., Muthoka, K., Ngeresa, A., et al. (2025) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2025.101953

Pediatric Residents’ HPV Knowledge and Awareness: A Pre-Post Training Study

Ünal, A., Çay, Ü., Gündeşli̇oğlu, Ö. Ö., & Alabaz, D. (2025) · Journal of Contemporary Medicine · doi:10.16899/jcm.1730371

The projected cost-effectiveness and budget impact of Alternative HPV Vaccines in Senegal: A Modelling StudyPreprint

Laraj, O., Diarra, M., Talla, C., Diop, R., Badiane, O., Pellé, K. G., Kebir, A., Loucoubar, C., & Miled, S. B. (2025) · medRxiv · doi:10.1101/2025.10.08.25337573

QUINTIP RECORDATI INITIAL DATA CONCERNING THE PECULIARITIES OF HUMAN PAPILLOMAVIRUS INFECTION EPIDEMIOLOGY IN UKRAINE AND THE PROSPECTS FOR ITS PREVENTION

Рыбин, А. И., Osyk, V. V., Vastyanov, R. S., Liskovskyi, S., & Artyomenko, V. (2025) · World of Medicine and Biology · doi:10.26724/2079-8334-2025-3-93-242-250

Human papillomavirus infection and vaccination among young females in rural Uganda

Newton, R., Tenet, V., Mugisha, J. O., Kimono, B., Vorsters, A., Bell, M., & Clifford, G. M. (2025) · International Journal of Cancer · doi:10.1002/ijc.70227

HPV T-cell epitope landscape: systematic mapping of distribution, conservation, and HLA promiscuity of known epitopes to inform immune-monitoring and vaccine designPreprint

Putra, S. P., Cankat, S., & Swadling, L. (2025) · medRxiv · doi:10.1101/2025.11.03.25339381

Caractéristiques obstétricales liées au cancer du col utérin dans le territoire nord de la région Rabat-Sale-Kenitra, Maroc

Zraidi, M., Kamel, N., Belloute, G. E., & Abidi, K. (2025) · Pan African Medical Journal · doi:10.11604/pamj.2025.52.102.44900

Risk of cancer among individuals with a history of bacterial sexually transmitted infections: A population‐based study in Alberta, Canada

Qureshi, H. M., Hughes, T., Franco, E. L., Fiest, K. M., Gratrix, J., Smyczek, P., Read, R. R., Afzal, A. R., Deardon, R., Kassam, A., et al. (2025) · International Journal of Cancer · doi:10.1002/ijc.70215

Multimodal photothermal therapy for gynecologic neoplasms: Clinical development and potential

Xu, Y., Zhang, Y. F., Wang, Y., He, C., Jin, W., Pan, J., Shi, J., Ding, B. Y., & Shen, Y. (2025) · Materials & Design · doi:10.1016/j.matdes.2025.115140

Human papillomavirus (HPV) genotypes extended prevalence in the female population from a city in Northern Chile

Escobar, V. J., Catalán, A., Callejas, V., Araya, R., Rojas, J., García, J., Alday, A., Martin, T., Santoro, K. I., Campillay-Véliz, C. P., et al. (2025) · BMC Women s Health · doi:10.1186/s12905-025-04179-z

HPV Genomic Status in Early Cervical Cancer and Its Prognosis Association

Doghman, I., Macias, R. M., Malassigné, V., Puech, J., Imbeaud, S., Frère‐Belda, M. L., Rigolet, P., Boulhic, M., Stankovic, I., Ángeles, M. A., et al. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70720

HPV binding antibodies are associated with protection: a meta-analysisPreprint

Berry, M. T., Palmer, M. R., Khan, S. R., Bowden-Reid, E., Egilmezer, E., Smith, M. A., Bateson, D. J., Canfell, K., Davenport, M. P., & Khoury, D. S. (2025) · medRxiv · doi:10.1101/2025.11.26.25341002

Public health impact, cost-effectiveness, and budget impact of HPV vaccination in Kazakhstan: a stakeholder engagement and modelling study

Young, G. T. B., Kassymova, S., Zhang, P., Syla, S., Clark, A., Sadykova, T., Sukhanberdiyev, K., & Abbas, K. (2026) · Vaccine X · doi:10.1016/j.jvacx.2026.100845

Landscape Analysis of Human Papillomavirus (HPV) Prophylactic Vaccine Clinical Trials in China Based on the NMPA Database

He, G., Huang, Y., Zhang, X., Yuan, L., Jiang, H., Hong, L., & Zeng, T. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s562608

Human papillomavirus infection and vaccination with thyroid diseases: mechanistic links and immunological insights

Wang, Z., Chang, X., & Cheng, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1732358

Cervical high-risk human papillomavirus infection and its associated risk factors: a community-based cross-sectional study in hard-to-reach areas in Bangladesh

Nazrul, N., Rahman, A., de Fouw, M., Campbell, C., Koot, J. A. R., Kulsum, M. U., Ahmed, M. S., Haider, S. S., Hossain, M. A., Islam, K. M., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-103915 · Cited by 1

Prevención del cáncer cervicouterino mediante vacunación y tamizaje del virus del papiloma humano [Prevention of cervical cancer through vaccination and screening for human papillomavirus]

Armas-Herrera, D. L., Inca-Procel, A. M., & Villegas-Silva, D. A. (2025) · Cuaderno de enfermería. Revista científica. · doi:10.62574/0jd0c294

Infección y prevención del virus del papiloma humano (VPH)

Valero, J. D. L. F. (2025) · Pediatría Integral · doi:10.63149/j.pedint.95

Risk Factors and Predictive Model for Persistent HPV Infection in Cervical Low-Grade Squamous Intraepithelial Lesion Patients with High-Grade HPV Infection Post-Treatment

Ye, X., Zhang, X., Yu, L., Zheng, C., Hong, X., Wang, F., & Wang, L. (2025) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-025-02277-4

Causal Attribution of Human Papillomavirus Types to Invasive Cervical Cancer Worldwide: A Systematic Analysis of the Global LiteraturePreprint

Wei, F., Georges, D., Man, I., Baussano, I., & Clifford, G. M. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4692586 · Cited by 4

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

de Sanjose, S., Quint, W. G., Alemany, L., Geraets, D. T., Klaustermeier, J. E., Lloveras, B., Tous, S., Felix, A., Bravo, L. E., Shin, H.-R., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70230-8 · Cited by 2,728

HPV genotypes: implications for worldwide cervical cancer screening and vaccination

de Sanjosé, S. (2010)

Identification of HPV genotypes causing cervical precancer using tissue‐based genotyping

Venetianer, R., Clarke, M. A., van der Marel, J., Tota, J. E., SCHIFFMAN, M. H., Dunn, S. T., Walker, J. L., Zuna, R. E., Quint, W. G. V., & Wentzensen, N. (2020) · International Journal of Cancer · doi:10.1002/ijc.32919 · Cited by 23

Ranking the attribution of high-risk genotypes among women with cervical precancers and cancers: a cross-sectional study in Ningbo, China

Chen, S., Hu, S., Yin, J., Yu, W., Zhang, X., Deng, X., Ding, H., Zhang, J., Song, Y. Y., Wang, Q., et al. (2024) · Infectious Agents and Cancer · doi:10.1186/s13027-024-00598-z · Cited by 1